These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15056060)

  • 1. Venous thromboembolism and malignancy.
    Gao S; Escalante C
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):303-20. PubMed ID: 15056060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and venous thromboembolism: a multidisciplinary approach.
    Sørensen HT; Johnsen SP; Nørgård B; Zacharski LR; Baron JA
    Clin Lab; 2003; 49(11-12):615-23. PubMed ID: 14651332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer and venous thromboembolism.
    Piccioli A; Falanga A; Baccaglini U; Marchetti M; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):694-9. PubMed ID: 17024596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism and cancer: risks and outcomes.
    Lee AY; Levine MN
    Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).
    Mandalà M; Falanga A; Piccioli A; Prandoni P; Pogliani EM; Labianca R; Barni S;
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):194-204. PubMed ID: 16837209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
    Winter PC
    Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the diagnosis and treatment of deep vein thrombosis: a regional consensus.
    Qari M; Abdel-Razeq H; Alzeer A; Alizadeh H; Kristensen J; al-Sayegh F; Qutub H; Marashi M; Husted S; Mousa S
    Curr Opin Investig Drugs; 2003 Mar; 4(3):309-15. PubMed ID: 12735232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in oncology.
    Falanga A; Vignoli A
    Eksp Onkol; 2004 Mar; 26(1):11-4. PubMed ID: 15112573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological thromboembolic prophylaxis for medical patients in a tertiary care, teaching community hospital: room for improvement.
    Jubelirer SJ; Reyes Bj; Broce M; Elhabyan AK; Mimnagh K; Rosencrance JG; Warwick T; Emmett MK
    W V Med J; 2008; 104(1):10-4. PubMed ID: 18335779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer related thrombophilia: clinical importance and management strategies.
    Gupta PK; Charan VD; Kumar H
    J Assoc Physicians India; 2005 Oct; 53():877-82. PubMed ID: 16459532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes.
    Paneesha S; Cheyne E; French K; Bacchu S; Borg A; Rose P
    Br J Haematol; 2006 Oct; 135(1):85-90. PubMed ID: 16925794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.